1-4 of 4
Rongwei Li, MD
Close
Sort by
Journal Articles

Drug-sensitivity of resistant acute myeloid leukemia cell line to Doxorubicin is enhanced by Triptolide through down-regulation of HIF-1α and Nrf2

Bing Xu, MD, Feili Chen, M.D., Yuejian Liu, M.D., Shiyun Wang, M.D., Rongwei Li, MD, Huijuan Dong, MD
Journal: Blood
Blood (2013) 122 (21): 4921.
https://doi.org/10.1182/blood.V122.21.4921.4921
Published: 2013
Journal Articles

Imatinib-induced apoptosis could be enhanced by Triptolide in Imatinib-resistant chronic myeloid leukemia cell line through down-regulation of HIF-1αand Nrf2

Bing Xu, MD, Feili Chen, M.D., Yuejian Liu, M.D., Shiyun Wang, M.D., Rongwei Li, MD, Huijuan Dong, MD, Jie Zha, M.D.
Journal: Blood
Blood (2013) 122 (21): 4928.
https://doi.org/10.1182/blood.V122.21.4928.4928
Published: 2013
Journal Articles

Disulfiram, an clinically used anti-alcoholism drug has the potential to target acute myeloid leukemia cells in a copper-dependent manner in vivo

Bing Xu, MD, Rongwei Li, MD, Huijuan Dong, MD, Feili Chen, M.D., Yuejian Liu, M.D., Shiyun Wang, M.D., Shuyun Zhou, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5040.
https://doi.org/10.1182/blood.V122.21.5040.5040
Published: 2013
Journal Articles

Low-dose Triptolide in combination with Idarubicin could induce apoptosis in leukemia stem and progenitor cells via affecting the intrinsic and extrinsic factors

Bing Xu, MD, Yuejian Liu, M.D., Feili Chen, M.D., Rongwei Li, MD, Shiyun Wang, M.D., Huijuan Dong, MD, Weiguang Wang, M.D. PhD
Journal: Blood
Blood (2013) 122 (21): 5410.
https://doi.org/10.1182/blood.V122.21.5410.5410
Published: 2013